Continuous subcutaneous infusions like pLD/pCD improve motor control and quality of life; however, skin adverse events may lead to treatment discontinuation in some casesWe propose an algorithm that aids HCP in dermatologic evaluation of patients undergoing continuous subcutaneous infusionsEmpowering HCPs ...
intestinal levodopa gellevodopa-carbidopaND0612advanced parkinson’s diseasesubcutaneousIntroduction Parkinson's disease (PD) is the second most common neurodegenerative disease and is growing in prevalence and disability. The standard treatment for PD is oral levo-dopa (LD) with carbidopa (CD). As PD...